Search Results

Discontinuation of Vioxx.

• Authors : Kim PS (AUTHOR); Reicin AS (AUTHOR); Lièvre M (AUTHOR)

• Source: Lancet. 1/1/2005, Vol. 365 Issue 9453, p23-28. 6p.

Record details

Cyclo-oxygenase-2 inhibitors and cardiovascular events.

• Authors : Warner TD (AUTHOR); Mitchell JA (AUTHOR); Vane JR (AUTHOR)

• Source: Lancet. 11/23/2002, Vol. 360 Issue 9346, p1700-1701. 2p.

Record details

50 years of informatics research on decision support: what's next.

• Authors : Mitchell JA; Gerdin U; Lindberg DA

• Source: Methods of Information in Medicine; 2011, Vol. 50 Issue 5, p525-535, 11p

Record details

Parental and environmental correlates of physical activity of children attending preschool.

• Authors : Dowda M; Pfeiffer KA; Brown WH

• Source: Archives of Pediatrics & Adolescent Medicine; Oct2011, Vol. 165 Issue 10, p939-944, 6p

Record details

International efforts in nanoinformatics research applied to nanomedicine.

• Authors : de la Iglesia D; Maojo V; Chiesa S

• Source: Methods of Information in Medicine; 2011, Vol. 50 Issue 1, p84-95, 12p

Record details

Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.

• Authors : Kapoor A; Shintani Y; Collino M

• Source: American Journal of Respiratory & Critical Care Medicine; 12/15/2010, Vol. 182 Issue 12, p1506-1515, 10p

Record details

Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophages.

• Authors : Moreno, L; McMaster, SK; Gatheral, T

Subjects: NUCLEOTIDES; OLIGOMERS; VASCULAR smooth muscle

• Source: British Journal of Pharmacology; Aug2010, Vol. 160 Issue 8, p1997-2007, 11p, 6 Graphs

Record details

Medical informatics in a united and healthy Europe. Nanoinformatics: new challenges for biomedical informatics at the nano level.

• Authors : de la Iglesia D; Chiesa S; Kern J

• Source: Studies in Health Technology & Informatics; 2009, Vol. 150, p987-991, 5p

Record details

Toll-like receptor 2 is essential for the sensing of oxidants during inflammation.

• Authors : Paul-Clark MJ; McMaster SK; Sorrentino R

• Source: American Journal of Respiratory & Critical Care Medicine; Feb2009, Vol. 179 Issue 4, p299-306, 8p

Record details

Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo.

• Authors : Cartwright N; Murch O; McMaster SK

• Source: American Journal of Respiratory & Critical Care Medicine; Mar2007, Vol. 175 Issue 6, p595-603, 9p

Record details